New technology targets cancer, other diseases, and hidden elements that allow those diseases to thrive
A Purdue-affiliated startup is developing a platform aimed at treating relapse patients for cancers and other diseases. KinaRx has licensed through the Purdue Research Foundation Office of Technology Commercialization a series of drug compounds that have shown promise in treating patients who have a recurrence of acute myeloid leukemia.